Weight loss injections have turned into a cultural flashpoint, but the search for something gentler and more "natural" has been building in parallel. Now, early research on a molecule produced inside the body suggests scientists may be edging closer to a biological counterpart that mimics some of Ozempic's benefits without being a lab‑designed drug.

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly injection has been shown to be as effective as Mounjaro – but patients

Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.

For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re paying out of pocket.

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for many patients.

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month. Then the monthly cost will rise to $349.

It is actually Mounjaro or Ozempic, drugs that help control blood sugar levels in diabetic people. However, their use in Morocco is limited.

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what causes it, and whether science can prevent it.

Increasingly, Ozempic is being bought without a doctor’s prescription by people who simply want to lose weight.

Someone’s weight can be an extremely sensitive topic, and in some scenarios, it may be the make or break in a relationship. With one Brazilian influencer, that was unfortunately the case. Débora Dunhill revealed to local news outlet O Globo that her ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.